Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children
- PMID: 17170721
- DOI: 10.1038/sj.leu.2404495
Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children
Abstract
The objective of the study was to assess acute neurotoxicity associated with triple intrathecal therapy (TIT)+/-high-dose methotrexate (HD MTX) in children with acute lymphoblastic leukemia (ALL). 1395 children were enrolled on FRALLE 93 protocol from 1993 to 1999. Lower-risk group (LR, n=182) were randomized to weekly low-dose MTX at 25 mg/m(2)/week (LD MTX, n=81) or HD MTX at 1.5 g/m(2)/2 weeks x 6 (n=77). Intermediate-risk group (IR, n=672) were randomized to LD MTX (n=290) or HD MTX at 8 g/m(2)/2 weeks x 4 (n=316). Higher-risk group (HR, n=541) prednisone-responder patients received LD MTX and cranial radiotherapy. HR group steroid resistant cases were grafted (autologous or allogenic). TIT (MTX, cytarabine and methylprednisolone) was given every 2 weeks during 16-18 weeks and every 3 months during maintenance therapy in LR and IR patients. 52 patients (3.7%) developed neurotoxicity. Isolated seizures: n=15 (1.1%), peripheral and spinal neuropathy: n=17 (1.2%) and encephalopathy: n=20 (1.4%). Age >10 years was significantly associated with neurotoxicity (P=0.01) and use of HD MTX is associated with encephalopathy (P=0.03). Sequels are reported respectively in 60 and 33% of spinal neuropathy and encephalopathy cases. Current strategies tailoring risk of neurological sequels has to be defined.
Similar articles
-
Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.Klin Padiatr. 1998 Jul-Aug;210(4):192-9. doi: 10.1055/s-2008-1043878. Klin Padiatr. 1998. PMID: 9743952 Clinical Trial.
-
Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.J Clin Oncol. 2006 Aug 20;24(24):3858-64. doi: 10.1200/JCO.2006.05.9055. J Clin Oncol. 2006. PMID: 16921038
-
Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.Haematologica. 1998 Sep;83(9):791-9. Haematologica. 1998. PMID: 9825576 Clinical Trial.
-
[Transient subacute encephalopathy induced by high-dose methotrexate treatment in children with acute lymphoblastic leukemia and malignant lymphoma].Gan To Kagaku Ryoho. 1992 Sep;19(11):1851-7. Gan To Kagaku Ryoho. 1992. PMID: 1519928 Review. Japanese.
-
Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.Isr Med Assoc J. 2002 Nov;4(11):1050-3. Isr Med Assoc J. 2002. PMID: 12489505 Review.
Cited by
-
Methotrexate-induced Transient Encephalopathy in an Adolescent and Young Adult Patient with Acute Lymphoblastic Leukemia.Intern Med. 2021 Jul 1;60(13):2115-2118. doi: 10.2169/internalmedicine.5937-20. Epub 2021 Feb 1. Intern Med. 2021. PMID: 33518561 Free PMC article.
-
The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).PLoS One. 2022 Sep 30;17(9):e0274634. doi: 10.1371/journal.pone.0274634. eCollection 2022. PLoS One. 2022. PMID: 36178925 Free PMC article.
-
Predictors of Chemotherapy Induced Adverse Events in Pediatric Osteosarcoma Patients.Asian Pac J Cancer Prev. 2022 Jan 1;23(1):93-100. doi: 10.31557/APJCP.2022.23.1.93. Asian Pac J Cancer Prev. 2022. PMID: 35092376 Free PMC article.
-
Magnetization transfer imaging provides no evidence of demyelination in methotrexate-induced encephalopathy.AJNR Am J Neuroradiol. 2011 Jun-Jul;32(6):E110-2. doi: 10.3174/ajnr.A2181. Epub 2010 Jul 22. AJNR Am J Neuroradiol. 2011. PMID: 20651019 Free PMC article.
-
Effect of methotrexate/vitamin B12 on DNA methylation as a potential factor in leukemia treatment-related neurotoxicity.Epigenomics. 2017 Sep;9(9):1205-1218. doi: 10.2217/epi-2016-0165. Epub 2017 Aug 15. Epigenomics. 2017. PMID: 28809129 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials